Related Experiment Video
Updated: Jul 13, 2026
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Increased translocator protein (TSPO) mRNA levels in colon but not in rectum carcinoma
I Königsrainer1, U F Vogel, S Beckert
1Department of General, Visceral and Transplant Surgery, Tübingen University Hospital, Tübingen, Germany. ikoenigsrainer@web.de
Background:
The peripheral-type benzodiazepine receptor or translocator protein (TSPO) is an 18-kDa protein involved in cell proliferation and apoptosis. TSPO was shown to be overexpressed in malignant tumors and cancer cell lines, correlating with enhanced malignant behavior. The present study analyzed the role of TSPO in patients with colorectal carcinomas.
Methods:
Tumor tissues and corresponding normal mucosa from 55 patients who underwent resection for colorectal carcinomas were analyzed for TSPO expression in correlation to GAPDH expression(glyceraldehyde-3-phosphate dehydrogenase) using a multiplex RT-PCR assay.
Results:
TSPO was overexpressed in 67% of the tumors in comparison to corresponding normal mucosa, and positivity as well as expression levels in colon carcinomas were significantly higher than in the rectum carcinomas. In contrast, TSPO expression was not different in intermediate versus high-grade tumors or in lymph node-positive versus -negative patients.
Conclusion:
The differences in TSPO expression between colon and rectum carcinoma may imply that these tumors are of different biological behavior.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters